Artificial Intelligence (AI) In Biopharmaceuticals Global Market Report 2026

Description

Artificial intelligence (AI) in biopharmaceuticals refers to the use of various AI techniques to analyze complex biological data and enhance different stages of drug discovery, development, and delivery within the pharmaceutical sector. AI in biopharmaceuticals has significant potential to transform these processes by speeding up timelines, lowering costs, and increasing the efficiency and effectiveness of treatments.

The main categories of offerings in AI in biopharmaceuticals include hardware, software, and services. Hardware consists of the physical components of a computer system, such as memory, disk drives, controllers, and specialized software like database management systems. These offerings involve different deployment models, including cloud and on-premises, and utilize technologies such as machine learning, natural language processing, and deep learning. Their applications span business processes and supply chains, drug discovery, medical imaging and diagnostics, and precision medicine. End users include manufacturers, contract research organizations, and academic and government research institutes.

Tariffs have impacted the ai in biopharmaceuticals market by increasing the cost of importing high-performance computing systems, ai-enabled laboratory equipment, and specialized software, thereby affecting drug discovery and clinical trial processes. Segments such as hardware and software are most affected, with regions like North America and Europe facing higher costs due to dependency on imported technology. While tariffs have temporarily raised expenses, they have also encouraged local manufacturing and innovation in ai tools, potentially creating long-term efficiencies in biopharmaceutical research.

The artificial intelligence (ai) in biopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (ai) in biopharmaceuticals market statistics, including artificial intelligence (ai) in biopharmaceuticals industry global market size, regional shares, competitors with a artificial intelligence (ai) in biopharmaceuticals market share, detailed artificial intelligence (ai) in biopharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai) in biopharmaceuticals industry. This artificial intelligence (ai) in biopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (ai) in biopharmaceuticals market size has grown exponentially in recent years. It will grow from $2.1 billion in 2025 to $2.79 billion in 2026 at a compound annual growth rate (CAGR) of 33.0%. The growth in the historic period can be attributed to early adoption of ai in pharma research, increasing computational power, rising investment in biopharmaceutical r&d, integration of omics data, growth of cloud-based data storage.

The artificial intelligence (ai) in biopharmaceuticals market size is expected to see exponential growth in the next few years. It will grow to $8.77 billion in 2030 at a compound annual growth rate (CAGR) of 33.1%. The growth in the forecast period can be attributed to advancements in machine learning algorithms, expansion of ai-enabled lab equipment, increased adoption of predictive analytics, rise in collaborative ai-biopharma platforms, government incentives for ai-driven healthcare. Major trends in the forecast period include ai-driven drug discovery, predictive analytics for clinical trials, automation in laboratory processes, real-world data integration, personalized treatment optimization.

The rising prevalence of chronic diseases is expected to drive the growth of the artificial intelligence (AI) in biopharmaceuticals market in the coming years. Chronic diseases are long-term conditions that typically progress slowly and may persist for years or even a lifetime. They result from lifestyle factors, an aging population, genetic predispositions, and environmental influences. AI in biopharmaceuticals is increasingly applied to manage chronic diseases by analyzing large volumes of diverse data, identifying patterns, and personalizing treatment strategies. For instance, in April 2025, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, reported that in 2023, approximately 194 million U.S. adults, or 76.4%, had at least one chronic condition. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the growing prevalence of chronic diseases is supporting growth in the artificial intelligence (AI) in biopharmaceuticals market.

Major companies in the artificial intelligence (AI) in biopharmaceuticals market are focusing on developing innovative solutions such as AI-powered target and lead identification suites to accelerate drug discovery and precision medicine, transforming life sciences organizations. These solutions support drug discovery and precision medicine through innovative approaches for developing new therapies and tailoring treatments to individual patients. For instance, in May 2023, Google LLC, a US-based provider of cloud computing services, launched two AI-powered tools called the target and lead identification suites, designed to help researchers predict and understand protein structures, which are essential for drug development. The suite also enables researchers to ingest, store, analyze, and share large volumes of genomic data, critical for precision medicine. Additionally, these tools aim to streamline drug discovery, reduce costs, and accelerate the delivery of new treatments. By providing efficient data management, accurate protein structure predictions, and advanced genomic analysis, these tools aim to transform drug development and improve patient outcomes.

In February 2023, ZS Associates, a US-based management consulting and technology firm, acquired Trials.ai Inc. for an undisclosed amount. Through this acquisition, ZS Associates aims to enhance design processes in the pharmaceutical industry by leveraging AI to optimize speed, improve participant experiences, and expedite the delivery of pharmaceutical therapies to market. Trials.ai Inc. is a US-based company specializing in revolutionizing clinical trials using artificial intelligence (AI) and machine learning (ML) technologies.

Major companies operating in the artificial intelligence (ai) in biopharmaceuticals market are Exscientia Limited, DeepMind Technologies Limited, Schrodinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in biopharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (ai) in biopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) in biopharmaceuticals market consists of revenues earned by entities by services such as drug discovery, personalized medicine analytics, clinical trial optimization, healthcare decision support, and data integration and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in biopharmaceuticals market also includes of sales of decision support System, predictive modeling tools, robotics, and automation systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) In Biopharmaceuticals Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai) in biopharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) in biopharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) in biopharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Offering: Hardware; Software; Services
2) By Deployment: Cloud; On-Premises
3) By Technology: Machine Learning; Natural Language Processing; Deep Learning; Other Technologies
4) By Application: Drug Discovery; Precision Medicine
5) By End-Users: Manufacturers; Contract Research Organizations; Academic And Government Research Institutes
Subsegments:
1) By Hardware: High-Performance Computing Systems; AI-Enabled Laboratory Equipment; Data Storage Solutions
2) By Software: Drug Discovery Platforms; Predictive Analytics Tools; Natural Language Processing Solutions
3) By Services: Consulting Services; Implementation And Integration Services; Data Management And Analytics Services; Training And Support Services
Companies Mentioned: Exscientia Limited; DeepMind Technologies Limited; Schrodinger Inc.; XtalPi Inc.; ConcertAI Inc.; Insilico Medicine Inc.; Recursion Pharmaceuticals; BenevolentAI; BioXcel Therapeutics; Atomwise Inc.; BioAge Labs Inc.; GNS Healthcare; Berg Health; Deep 6 AI Inc.; Cloud Pharmaceuticals Inc.; Numerate Inc.; AI Therapeutics; Envisagenics; twoXAR Inc.; Cyclica Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH3MAIAB02_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI) In Biopharmaceuticals Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI) In Biopharmaceuticals Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Artificial Intelligence & Autonomous Intelligence
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Biotechnology, Genomics & Precision Medicine
- 4.1.4 Industry 4.0 & Intelligent Manufacturing
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Ai-Driven Drug Discovery
- 4.2.2 Predictive Analytics For Clinical Trials
- 4.2.3 Automation In Laboratory Processes
- 4.2.4 Real-World Data Integration
- 4.2.5 Personalized Treatment Optimization

5. Artificial Intelligence (AI) In Biopharmaceuticals Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies
5.2 Biotechnology Firms
5.3 Contract Research Organizations
5.4 Academic Research Institutes
5.5 Government Research Institutes

6. Artificial Intelligence (AI) In Biopharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI) In Biopharmaceuticals Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Artificial Intelligence (AI) In Biopharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Size, Comparisons And Growth Rate Analysis
7.3. Global Artificial Intelligence (AI) In Biopharmaceuticals Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI) In Biopharmaceuticals Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI) In Biopharmaceuticals Market Segmentation

9.1. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hardware, Software, Services
9.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cloud, On-Premises
9.3. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Machine Learning, Natural Language Processing, Deep Learning, Other Technologies
9.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Drug Discovery, Precision Medicine
9.5. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Manufacturers, Contract Research Organizations, Academic And Government Research Institutes
9.6. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions
9.7. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Drug Discovery Platforms, Predictive Analytics Tools, Natural Language Processing Solutions
9.8. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

10. Artificial Intelligence (AI) In Biopharmaceuticals Market Regional And Country Analysis

10.1. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market

11.1. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Intelligence (AI) In Biopharmaceuticals Market

12.1. China Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Intelligence (AI) In Biopharmaceuticals Market

13.1. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market

14.1. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market

15.1. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market

16.1. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market

17.1. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Intelligence (AI) In Biopharmaceuticals Market

18.1. Taiwan Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Intelligence (AI) In Biopharmaceuticals Market

19.1. South East Asia Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market

20.1. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Intelligence (AI) In Biopharmaceuticals Market

21.1. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market

22.1. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Intelligence (AI) In Biopharmaceuticals Market

23.1. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market

24.1. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market

25.1. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market

26.1. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market

27.1. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Intelligence (AI) In Biopharmaceuticals Market

28.1. North America Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Intelligence (AI) In Biopharmaceuticals Market

29.1. USA Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market

30.1. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Intelligence (AI) In Biopharmaceuticals Market

31.1. South America Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market

32.1. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market

33.1. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market

34.1. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Intelligence (AI) In Biopharmaceuticals Market Regulatory and Investment Landscape

36. Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Landscape And Company Profiles

36.1. Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Artificial Intelligence (AI) In Biopharmaceuticals Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Artificial Intelligence (AI) In Biopharmaceuticals Market Company Profiles
- 36.3.1. Exscientia Limited Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. DeepMind Technologies Limited Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Schrodinger Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. XtalPi Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. ConcertAI Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Intelligence (AI) In Biopharmaceuticals Market Other Major And Innovative Companies

Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

38. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Biopharmaceuticals Market

40. Artificial Intelligence (AI) In Biopharmaceuticals Market High Potential Countries, Segments and Strategies

40.1 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2030 - Countries Offering Most New Opportunities
40.2 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2030 - Segments Offering Most New Opportunities
40.3 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer